Alx Oncology Holdings Inc SEC filings ALXO

Alx Oncology Holdings Inc has 421 filings in SEC EDGAR's recent list, going back to May 5, 2020. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Alx Oncology Holdings Inc SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 16, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Oct 15, 2026 Oct 14, 2026
4 Insider transaction Aug 18, 2026 Aug 17, 2026
4 Insider transaction Aug 18, 2026 Aug 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Jun 30, 2026 Jun 29, 2026
8-K Current report
Material agreement, Agreement ended, New debt
Jun 26, 2026 Jun 25, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2026 —
ARS Annual report to shareholders Apr 20, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 20, 2026 Apr 17, 2026
4 Insider transaction Apr 17, 2026 Apr 16, 2026
4 Insider transaction Apr 17, 2026 Apr 16, 2026
3 Initial insider ownership Apr 17, 2026 Apr 13, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 13, 2026 Apr 13, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
4 Insider transaction Mar 5, 2026 Mar 3, 2026
3 Initial insider ownership Mar 5, 2026 Feb 25, 2026
8-K Current report
Results of operations
Feb 27, 2026 Feb 27, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 4, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
424B5 Prospectus supplement Jan 30, 2026 —
8-K Current report
Material agreement, Other events
Jan 30, 2026 Jan 30, 2026
8-K Current report
Other events
Jan 30, 2026 Jan 30, 2026
4 Insider transaction Jan 28, 2026 Jan 26, 2026
4 Insider transaction Jan 28, 2026 Jan 26, 2026
4 Insider transaction Jan 28, 2026 Jan 26, 2026
S-8 Employee stock plan registration Jan 21, 2026 —
8-K Current report
Officer or director change
Jan 21, 2026 Jan 21, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 7, 2026 Jan 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 7, 2025 Nov 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 22, 2025 —
4 Insider transaction Oct 16, 2025 Oct 14, 2025
4 Insider transaction Oct 16, 2025 Oct 14, 2025
4 Insider transaction Oct 16, 2025 Oct 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 8, 2025 —
4 Insider transaction Sep 19, 2025 Sep 17, 2025
4 Insider transaction Sep 18, 2025 Sep 16, 2025
8-K Current report
Officer or director change, Other events
Sep 12, 2025 Sep 11, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 13, 2025 Aug 12, 2025
3 Initial insider ownership Aug 13, 2025 Aug 12, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change, Other events
Aug 12, 2025 Aug 12, 2025
4 Insider transaction Jul 8, 2025 Jul 7, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Listing notice
Apr 25, 2025 Apr 23, 2025
EFFECT Filing Apr 24, 2025 —
CORRESP Letter to the SEC Apr 23, 2025 —
ARS Annual report to shareholders Apr 21, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 21, 2025 Apr 21, 2025
4 Insider transaction Apr 15, 2025 Apr 11, 2025
4 Insider transaction Apr 15, 2025 Apr 11, 2025
4 Insider transaction Apr 15, 2025 Apr 11, 2025
4 Insider transaction Apr 15, 2025 Apr 11, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
UPLOAD Letter from the SEC Mar 11, 2025 —
S-3 Shelf registration Mar 6, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Exit or restructuring costs, Officer or director change
Mar 5, 2025 Feb 28, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
3 Initial insider ownership Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
3 Initial insider ownership Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
3 Initial insider ownership Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Jan 22, 2025 Jan 16, 2025
8-K Current report
Officer or director change
Jan 17, 2025 Jan 16, 2025
S-8 Employee stock plan registration Jan 17, 2025 —
4 Insider transaction Jan 8, 2025 Jan 6, 2025
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
SC TO-I/A Filing Dec 31, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Dec 27, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 6, 2024 —
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
SC TO-I Filing Dec 2, 2024 —
4 Insider transaction Nov 19, 2024 Nov 18, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Nov 14, 2024 Nov 8, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change
Nov 7, 2024 Nov 5, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 10, 2024 —
8-K Current report
Officer or director change
Oct 4, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Aug 22, 2024 —
4 Insider transaction Aug 16, 2024 Aug 14, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
SC 13G Ownership over 5% (passive) Aug 13, 2024 —
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
3 Initial insider ownership Aug 7, 2024 Aug 5, 2024
8-K Current report
Officer or director change, Other events
Aug 6, 2024 Aug 5, 2024
4 Insider transaction Jul 15, 2024 Jul 11, 2024
144 Notice of proposed sale Jul 11, 2024 —
4 Insider transaction Jul 9, 2024 Jul 5, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4/A Filing Jun 24, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 17, 2024 Jun 12, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
144 Notice of proposed sale Jun 4, 2024 —
4 Insider transaction May 15, 2024 May 13, 2024
144 Notice of proposed sale May 13, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
4 Insider transaction May 8, 2024 May 6, 2024
144 Notice of proposed sale May 6, 2024 —
DEFA14A Additional proxy material May 2, 2024 —
8-K Current report
Officer or director change
May 2, 2024 Apr 28, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 22, 2024 Jun 12, 2024
4 Insider transaction Apr 18, 2024 Apr 16, 2024
144 Notice of proposed sale Apr 16, 2024 —
4 Insider transaction Apr 5, 2024 Apr 4, 2024
144 Notice of proposed sale Apr 4, 2024 —
4 Insider transaction Mar 18, 2024 Mar 14, 2024
S-8 Employee stock plan registration Mar 8, 2024 —
10-K Annual report Mar 7, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
4 Insider transaction Jan 5, 2024 Jan 4, 2024
4 Insider transaction Jan 3, 2024 Dec 29, 2023
4 Insider transaction Jan 3, 2024 Dec 29, 2023
4 Insider transaction Jan 3, 2024 Dec 29, 2023
4 Insider transaction Jan 3, 2024 Dec 29, 2023
8-K Current report
Material agreement, New debt
Dec 26, 2023 Dec 22, 2023
SC 13D/A Amended ownership over 5% (active) Dec 20, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
SC 13G Ownership over 5% (passive) Oct 16, 2023 —
SC 13G Ownership over 5% (passive) Oct 13, 2023 —
8-K Current report
Material agreement, Other events
Oct 6, 2023 Oct 4, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ALXO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1810182

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.